Nunzia Pharmaceutical Company (NUNZ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Aug 11, 2025
NUNZ Statistics
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NUNZ has 434.51 million shares outstanding.
Current Share Class | 434.51M |
Shares Outstanding | 434.51M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.06% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -0.23 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
Current Ratio | 0.16 |
Quick Ratio | 0.16 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -52,080.97 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -270,239.11% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 50,686.94% |
Revenue Per Employee | n/a |
Profits Per Employee | -24.25M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.67% in the last 52 weeks. The beta is 3.52, so NUNZ's price volatility has been higher than the market average.
Beta (5Y) | 3.52 |
52-Week Price Change | -96.67% |
50-Day Moving Average | 0.08 |
200-Day Moving Average | 1.00 |
Relative Strength Index (RSI) | 33.68 |
Average Volume (20 Days) | 14,674 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -96.97M |
Pretax Income | -96.99M |
Net Income | -96.99M |
EBITDA | n/a |
EBIT | -96.97M |
Earnings Per Share (EPS) | -0.23 |
Balance Sheet
The company has 35,373 in cash and 183,345 in debt, giving a net cash position of -147,972 or -0.00 per share.
Cash & Cash Equivalents | 35,373 |
Total Debt | 183,345 |
Net Cash | -147,972 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -191,321 |
Book Value Per Share | -0.00 |
Working Capital | -191,321 |
Cash Flow
Operating Cash Flow | -202,004 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NUNZ does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -42.64% |
Shareholder Yield | n/a |
Earnings Yield | -223,206.86% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 4, 2019. It was a reverse split with a ratio of 0.0001428.
Last Split Date | Dec 4, 2019 |
Split Type | Reverse |
Split Ratio | 0.0001428 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |